[ad_1]
Farmakis, D., Stafylas, P., Giamouzis, G., Maniadakis, N. & Parissis, J. The medical and socioeconomic burden of heart failure: A comparative delineation with cancer. Int. J. Cardiol. 15(203), 279â281 (2016).
Google ScholarÂ
Savarese, G. et al. Global burden of heart failure: A comprehensive and updated review of epidemiology. Cardiovasc. Res. 118(17), 3272â3287 (2023).
Google ScholarÂ
Okura, Y. et al. Impending epidemic: Future projection of heart failure in Japan to the year 2055. Circ. J. 72(3), 489â491 (2008).
Google ScholarÂ
Rugiómez, A., Michel, A., MartÃn-Pérez, M. & RodrÃguez, L. A. G. Heart failure hospitalization: An important prognostic factor for heart failure re-admission and mortality. Int. J. Cardiol. 220, 855â861 (2016).
Google ScholarÂ
Bello, N. A. et al. Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. Circ. Heart Fail. 7(4), 590â595 (2014).
Google ScholarÂ
Jackson, S. L. et al. National burden of heart failure events in the United States, 2006 to 2014. Circ. Heart Fail. 11(12), e004873 (2018).
Google ScholarÂ
Störk, S. et al. Epidemiology of heart failure in Germany: A retrospective database study. Clin. Res. Cardiol. 106(11), 913â922 (2017).
Google ScholarÂ
Parizo, J. T., Kohsaka, S., Sandhu, A. T., Patel, J. & Heidenreich, P. A. Trends in readmission and mortality rates following heart failure hospitalization in the Veteran Affairs Health Care System from 2007 to 2017. JAMA Cardiol. 5(9), 1042â1047 (2020).
Google ScholarÂ
Ide, T. et al. Clinical characteristics and outcomes of hospitalized patients with heart failure from the large-scale Japanese registry of acute decompensated heart failure (JROADHF). Circ. J. 85(9), 1438â1450 (2021).
Google ScholarÂ
Akita, K. et al. Prognostic impact of previous hospitalization in acute heart failure patients. Circ. J. 83(6), 1261â1268 (2019).
Google ScholarÂ
Heidenreich, P. A. et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American Colledge of Cardiology/American heart Association joint committee on clinical practice guidelines. Circulation. 145(18), e895âe1032 (2022).
Google ScholarÂ
McDonagh, T. A. et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 42(36), 3599â3726 (2021).
Google ScholarÂ
Tsutsui, H. et al. JCS/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure. J. Cardiac. Fail. 27(12), 1404â1444 (2021).
Google ScholarÂ
Greene, S. J. et al. Clinical effectiveness of sacubitril/varsartan among patients hospitalized for heart failure with reduce ejection fraction. J. Am. Heart Assoc. 10(16), e021459 (2021).
Google ScholarÂ
Wirtz, H. S. et al. Real-world analysis of guideline-based therapy after hospitalization for heart failure. J. Am. Heart Assoc. 9(16), e015042 (2020).
Google ScholarÂ
Greene, S. J. et al. Medical therapy during hospitalization for heart failure with reduced ejection fraction. J. Cardiac. Fail. 28(7), 1063â1077 (2022).
Google ScholarÂ
DâAmario, D. et al. Assoctiation between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: data from the Swedish heart failure registry. Eur. J. Heart Fail. 24(5), 871â884 (2022).
Google ScholarÂ
Greene, S. J. et al. Medical therapy for heart failure with reduced ejection fraction: The CHAMP-HF registry. J. Am. Coll. Cardiol. 72(4), 351â366 (2018).
Google ScholarÂ
Peri-Okonny, P. A. et al. Target doses of heart failure medical therapy and blood presure: Insights from the CHAMP-HF registry. JACC Heart Fail. 7(4), 350â358 (2019).
Google ScholarÂ
Ito, M. et al. Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction. Sci. Rep. 12(1), 16611 (2022).
Google ScholarÂ
Savarese, G. et al. Heart failuredrug treatment – inertia, titration, and discontinuation: A multinational observational study (EVOLUTION HF). JACC Heart Fail. 11(1), 1â14 (2023).
Google ScholarÂ
Kaneko, H. et al. Characteristics and outcomes of super-elderly patients (aged ⥠90 yeas) hospitalized for heart failure analysis of a nationwide inpatient database. Circ. Rep. 2(8), 393â399 (2020).
Google ScholarÂ
Setoguchi, S., Stevenson, L. W. & Schneeweiss, S. Repeated hospitalizations predict mortality in the community population with heart failure. Am. Heart J. 154(2), 260â266 (2007).
Google ScholarÂ
Zomer, A. C. et al. Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. Int. J. Cardiol. 168(3), 2487â2493 (2013).
Google ScholarÂ
Eguchi, S. et al. Burden of repeated hospitalizations on patients with heart failure: An analysis of administrative and claims data in Japan. Drugs Real World Outcomes. 9(3), 377â389 (2022).
Google ScholarÂ
Hayashida, K., Murakami, G., Matsuda, S. & Fushimi, K. History and profile of diagnosis procedure combination (DPC): Development of a real data collection system for acute inpatient care in Japan. J. Epidemiol. 31(1), 1â11 (2021).
Google ScholarÂ
Louks, J. et al. Proportions of days covered as a measure of medication adherence. Am. J. Heath-Syst. Pharm. 79(6), 492â496 (2022).
Google ScholarÂ
von Elm, E. et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Ann. Int. Med. 147(8), 573â577 (2007).
Google ScholarÂ
Ministry of Labour, Health and Welfare of Japan. Ethical Guidelines for Medical and Health Research Involving Human Subjects. https://www.mhlw.go.jp/file/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka/0000080278.pdf. Accessed on 27 Dec 2023.
Tsutsui, H. et al. JCS 2017/JHFS 2017 guideline of diagnosis and treatment of acute and chronic heart failure. Circ. J. 83(10), 2084â2184 (2019).
Google ScholarÂ
Yasuda, S. et al. The current status of cardiovascular medicine in Japan: Analysis of a large number of health records from a nationwide claim-based database. Circ. J. 80(11), 2327â2335 (2016).
Google ScholarÂ
Baxter, A. J. et al. β blockers in older persons with heart failure: Torelability and impact of quality of life. Heart. 88(6), 611â614 (2002).
Google ScholarÂ
Verhestraeten, C., Heggermont, W. A. & Michael, M. Clinical inertia in the treatment of heart failure: A major issue to tackle. Heart Fail. Rev. 26(6), 1359â1370 (2021).
Google ScholarÂ
Packer, M. & Metra, M. Guideline-directed medical therapy for heart failure does not exist: A non-judgmental framework for describing the level of adherence to evidence-based drug treatments for patients with a reduced ejection fraction. Eur. J. Heart Fail. 22(10), 1759â1767 (2020).
Google ScholarÂ
Tang, K. L., Quan, H. & Rabi, D. M. Measuring medication adherence in patients with incident hypertension: A retrospctive cohort study. BMC Health Serv. Res. 17(1), 135 (2017).
Google ScholarÂ
Savarese, G. et al. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: A multinational observational study (US, UK, and Sweden). Eur. J. Heart Fail. 23(9), 1499â1511 (2021).
Google ScholarÂ
Chang, L. L. et al. Timing of post discharge follow-up and medication adherence among patients with heart failure. J. Am. Heart Assoc. 7(7), e007998 (2018).
Google ScholarÂ
Nakai, M. et al. Age-dependent association of discharge heart-failure medications with clinical outcomes in a super-aged society. Biomed. Pharmacother. 155, 113761 (2022).
Google ScholarÂ
Bakal, J. A., McAlister, F. A., Liu, W. & Ezekowitz, J. A. Heart failure re-admission: Measuring the ever shortening gap between repeat heart failure hospitalizations. PLoS ONE. 9(9), e106494 (2014).
Google ScholarÂ
Butler, J. et al. Clinical course of patients with worsening heart failure with reduced ejection fraction. J. Am. Coll. Cardiol. 73(8), 935â944 (2019).
Google ScholarÂ
Tromp, J. et al. A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduce ejection fraction. JACC Heart Fail. 10(2), 73â84 (2022).
Google ScholarÂ
Mebazaa, A. et al. Safety, torelability, and efficacy of up-titration of guideline directed medical therapies for acute heart failure (STRONG-HF): A multinational, open-label, randomised, trial. Lancet. 400(10367), 1938â1952 (2022).
Google ScholarÂ
Reif, S. et al. Supporting patients with heart failure with digital therapeutics: A pilot study in Germany. Digit. Health. 8, 20552076221143900 (2022).
Google ScholarÂ
Denis, F. et al. Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer. JAMA. 321(3), 306â307 (2019).
Google ScholarÂ
Maclnnes, J. & Williams, L. A review of integrated heart failure care. Prim. Health Care Res. Dev. 20, e57 (2019).
Google ScholarÂ
[ad_2]
Source link